PTPN12 and angiosarcoma: Combined loss of Trp53, Pten and Ptpn12 also leads to the development of aggressive vascular lesions, which was associated with both mTORC and MEK pathway activation, suggesting that mTORC activation alone is not sufficient to drive aggressive angiosarcoma development (Chadwick et al., 2018).